Management of opportunistic infections after cardiac transplantation
| Organism | Test | Treatment |
|---|---|---|
| CMV, cytomegalovirus; CT computed tomography; IFT immunofluoresence test; CFT, complement fixation test. | ||
| Cytomegalovirus | IE-Gene, PCR, IgM | Gancyclovir, if severe additional CMV antibodies |
| Herpes simplex virus | IgM | Aciclovir |
| Varicella-zoster virus | IgM | Aciclovir |
| Hepatitis B virus | IgM | Lamivudine |
| Legionella species | Urine antigen, x ray | Erythromycin |
| Mycobacterium tuberculosis | Ziehl-Neelson | Rifampicin, isoniazid, myambutol |
| Nocardia asteroides | Brain CT | Sulfamethoxazole/trimethoprim |
| Pneumocystis carinii | x ray | Sulfamethoxazole/trimethoprim |
| Toxoplasma gondii | X ray, IFT, CFT, IgA, IgM | Pyrimethamine + sulfadiazine, folic acid |
| Candida albicans | Direct | Fluconazole, itraconazole |
| Aspergillus fumigatus | X ray | Itraconazole, amphotericin B, flucytosine |
| Cryptococcus neoformans | Brain CT | Itraconazole, amphotericin B, flucytosine, or fluconazole |
| Listeria monocytogenes | CNS: ampicillin + gentamycin | |